David E. Potter

3.8k total citations
131 papers, 3.1k citations indexed

About

David E. Potter is a scholar working on Molecular Biology, Physiology and Ophthalmology. According to data from OpenAlex, David E. Potter has authored 131 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 43 papers in Physiology and 41 papers in Ophthalmology. Recurrent topics in David E. Potter's work include Glaucoma and retinal disorders (41 papers), Receptor Mechanisms and Signaling (31 papers) and Neuropeptides and Animal Physiology (23 papers). David E. Potter is often cited by papers focused on Glaucoma and retinal disorders (41 papers), Receptor Mechanisms and Signaling (31 papers) and Neuropeptides and Animal Physiology (23 papers). David E. Potter collaborates with scholars based in United States, United Kingdom and Saudi Arabia. David E. Potter's co-authors include James A. Burke, J. Mark Rowland, Denys T. Lau, Judith D. Kasper, Alan Lyles, Richard G. Bennett, Teh‐Ching Chu, R. J. Reiter, Craig E. Crosson and Steven B. Cohen and has published in prestigious journals such as Biochemistry, Journal of Computational Physics and Pharmacological Reviews.

In The Last Decade

David E. Potter

130 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Potter United States 29 828 774 506 464 434 131 3.1k
Wendy A. Davis Australia 48 681 0.8× 140 0.2× 34 0.1× 849 1.8× 292 0.7× 249 7.2k
J. P. Burke United States 39 500 0.6× 776 1.0× 183 0.4× 221 0.5× 17 0.0× 100 5.6k
C. T. Dollery United Kingdom 62 2.3k 2.8× 1.1k 1.5× 932 1.8× 3.1k 6.7× 155 0.4× 310 15.2k
Elizabeth R. Seaquist United States 45 1.5k 1.9× 68 0.1× 827 1.6× 1.7k 3.7× 92 0.2× 152 10.0k
James E. Galvin United States 36 588 0.7× 28 0.0× 1.0k 2.0× 1.6k 3.5× 209 0.5× 170 6.1k
William E. Wilkinson United States 36 312 0.4× 39 0.1× 249 0.5× 660 1.4× 147 0.3× 86 6.5k
Hans Persson Sweden 41 938 1.1× 412 0.5× 297 0.6× 307 0.7× 73 0.2× 155 6.0k
Leo T. Chylack United States 37 2.2k 2.7× 1.1k 1.4× 105 0.2× 689 1.5× 21 0.0× 102 4.4k
Chris Boesch Switzerland 62 1.5k 1.8× 111 0.1× 322 0.6× 3.3k 7.2× 35 0.1× 232 11.6k
Michaëla Diamant Netherlands 64 5.4k 6.5× 127 0.2× 438 0.9× 2.7k 5.7× 148 0.3× 227 19.5k

Countries citing papers authored by David E. Potter

Since Specialization
Citations

This map shows the geographic impact of David E. Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Potter more than expected).

Fields of papers citing papers by David E. Potter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Potter. The network helps show where David E. Potter may publish in the future.

Co-authorship network of co-authors of David E. Potter

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Potter. A scholar is included among the top collaborators of David E. Potter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Potter. David E. Potter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Junqing, Jonathan B. Brown, Suzanne Morton, et al.. (2017). Disparities in diabetes and hypertension care for individuals with serious mental illness.. PubMed. 23(5). 304–308. 8 indexed citations
2.
Husain, Shahid, David E. Potter, & Craig E. Crosson. (2008). Opioid Receptor Activation Protects the Retina from Ischemic Injury by Suppressing the Activity of TNF. Investigative Ophthalmology & Visual Science. 49(13). 2008–2008. 1 indexed citations
3.
Husain, Shahid & David E. Potter. (2008). The Opioidergic System: Potential Roles and Therapeutic Indications in the Eye. Journal of Ocular Pharmacology and Therapeutics. 24(2). 117–140. 8 indexed citations
4.
Chu, Teh‐Ching, Qing He, & David E. Potter. (2002). Biodegradable Calcium Phosphate Nanoparticles as a New Vehicle for Delivery of a Potential Ocular Hypotensive Agent. Journal of Ocular Pharmacology and Therapeutics. 18(6). 507–514. 28 indexed citations
5.
Chu, Teh‐Ching & David E. Potter. (2002). Ocular Hypotension Induced by Electroacupuncture. Journal of Ocular Pharmacology and Therapeutics. 18(4). 293–305. 25 indexed citations
6.
Russell, Karen, et al.. (2001). Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides. 35(5-6). 232–237. 9 indexed citations
7.
Chu, Teh‐Ching, et al.. (1999). Intraocular Pressure Lowering by S-allylmercaptocysteine in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 15(1). 9–17. 4 indexed citations
8.
Cohen, J, Alan C. Monheit, Karen Beauregard, et al.. (1997). The Medical Expenditure Panel Survey: a national health information resource.. PubMed. 33(4). 373–89. 297 indexed citations
9.
Potter, David E., et al.. (1995). Centrally Mediated Ocular Hypotension: Potential Role of Imidazoline Receptorsfn1. Annals of the New York Academy of Sciences. 763(1). 463–485. 19 indexed citations
10.
Potter, David E., et al.. (1994). Potential Role of Imidazoline (I 1 ) Receptors in Modulating Aqueous Humor Dynamics. Journal of Ocular Pharmacology and Therapeutics. 10(1). 393–402. 11 indexed citations
11.
Chu, Teh‐Ching, et al.. (1993). Allicin-Induced Hypotension in Rabbit Eyes. Journal of Ocular Pharmacology and Therapeutics. 9(3). 201–209. 15 indexed citations
12.
Potter, David E.. (1990). Functional foods - a major opportunity for the dairy industry?. 55(6). 16–17. 4 indexed citations
13.
Crosson, Craig E., James Willis, & David E. Potter. (1990). Effect of the Calcium Antagonist, Nifedipine, on Ischemic Retinal Dysfunction. Journal of Ocular Pharmacology and Therapeutics. 6(4). 293–299. 50 indexed citations
14.
Potter, David E., et al.. (1990). Alpha 2 and DA 2 Agonists as Antiglaucoma Agents: Comparative Pharmacology and Clinical Potential. Journal of Ocular Pharmacology and Therapeutics. 6(3). 251–257. 17 indexed citations
15.
Woodward, David F., Gary D. Novack, Leon Williams, A L Nieves, & David E. Potter. (1987). Dihydrolevobunolol is a Potent Ocular β-adrenoceptor Antagonist. Journal of Ocular Pharmacology and Therapeutics. 3(1). 11–15. 12 indexed citations
16.
Potter, David E., et al.. (1987). Cianergoline Lowers Intraocular Pressure in Rabbits and Monkeys and Inhibits Contraction of the Cat Nictitans by Suppressing Sympathetic Neuronal Function. Journal of Ocular Pharmacology and Therapeutics. 3(4). 309–321. 15 indexed citations
17.
Potter, David E., et al.. (1986). Effects of Ibuterol, a β-2 Adrenergic Prodrug, on Intraocular Pressure. Journal of Ocular Pharmacology and Therapeutics. 2(3). 225–237. 9 indexed citations
18.
Burke, James A. & David E. Potter. (1986). The Ocular Effects of Xylazine in Rabbits, Cats, and Monkeys. Journal of Ocular Pharmacology and Therapeutics. 2(1). 9–21. 36 indexed citations
19.
Potter, David E. & James A. Burke. (1985). Does B-HT 920 Lower Intraocular Pressure in Cats by Interacting with α 2 - and/or DA 2 Adrenoceptors?. Journal of Ocular Pharmacology and Therapeutics. 1(1). 29–45. 12 indexed citations
20.
Potter, David E. & James A. Burke. (1984). An in vivo model for dissociating α 2 - and DA 2 -adrenoceptor activity in an ocular adnexa: Utility of the cat nictitating membrane preparation. Current Eye Research. 3(11). 1289–1298. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy A. Davis Breakdown of academic impact, for papers by J. P. Burke Breakdown of academic impact, for papers by C. T. Dollery Breakdown of academic impact, for papers by Elizabeth R. Seaquist Breakdown of academic impact, for papers by James E. Galvin Breakdown of academic impact, for papers by William E. Wilkinson Breakdown of academic impact, for papers by Hans Persson Breakdown of academic impact, for papers by Leo T. Chylack Breakdown of academic impact, for papers by Chris Boesch Breakdown of academic impact, for papers by Michaëla Diamant
Rankless by CCL
2026